Di Pede C, Colombo E, Duso M, Conte D, Marcon V, Vianello A, Masiero S, Martinuzzi A. Reduction in respiratory exacerbation rate in patients with severe bilateral cerebral palsy following daily PEP-mask therapy: a retrospective study.
Eur J Phys Rehabil Med 2019;
56:68-72. [PMID:
31489811 DOI:
10.23736/s1973-9087.19.05794-0]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
BACKGROUND
Respiratory complications caused by the inability to protect the upper airways and ineffective cough represent a major cause of morbidity and mortality in patients with cerebral palsy (CP). Even though the application of positive end-expiratory pressure (PEP) through a face mask has gained large popularity as a technique to prevent bronchial mucous encumbrance, its long-term effects on clinical course and respiratory function in individuals with CP have not been investigated.
AIM
The aim of this study is to investigate whether regular application of PEP through a face mask can improve clinical status and respiratory function in patients with severe CP.
DESIGN
Observational, retrospective cohort study.
SETTING
The outpatient rehabilitation unit of the IRCCS E. Medea Rehabilitation Hospital in Conegliano, Italy.
POPULATION
CP outpatients admitted to the unit between January 1st, 2006 and December 31st, 2018.
METHODS
All the medical records of the enrolled patients were collected and reviewed. All patients underwent multidisciplinary respiratory evaluation at T0 (immediately before the beginning of PEP-use) and T1 (12 months after). The evaluation assessed respiratory infections history (number of exacerbations per year), blood gas analysis, measurement of airway resistance through the interrupter technique.
RESULTS
Twenty-one patients affected with CP (mean age 9.19±5.56 years, range 3-23 years, 8 females) were included. All patients had more than 3 infections per year (mean 4.81±1.17) in the year prior to treatment (T0). At T1 mean number of infections was 1.57±0.81); 17 patients (80%) reported less than three infections; two patients (10%) reported zero infections, two patients (10%) reported three infections. Blood gas analysis and airway resistance values did not show a significant difference at T0 and T1.
CONCLUSIONS
Daily PEP-mask therapy reduces frequency of respiratory exacerbations in patients with severe bilateral CP.
CLINICAL REHABILITATION IMPACT
PEP-mask is a valuable rehabilitative tool in severe CP patients with frequent respiratory exacerbations.
Collapse